- Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapiesRoche may have scrapped work on a T-cell engager being evaluated for lupus, but the company’s head of pharma told Fierce that still has a strategy for developing cell therapies for autoimmune disea…Fierce Biotech · 3d ago↗ source
- FDA clears Johnson & Johnson’s surgical robot for ‘the next era in surgery’The FDA has authorized Johnson & Johnson’s Ottava Robotic Surgical System as the company looks to compete with Intuitive Surgical and Medtronic.Fierce Biotech · 3d ago↗ source
- Webinar: From Clinical to Commercial: Talent Strategies for Biopharma GrowthThis webinar provides an assessment of recent job market activity across biopharma and explores how companies approaching commercial readiness or building out sales and marketing teams can navigate…